Skip to main content
Premium Trial:

Request an Annual Quote

Luminex, HTG Partner on Gene Expression Assay

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Luminex and High Throughput Genomics have partnered to develop an integrated assay that Luminex will sell to the gene expression research market.

Luminex said today that the new qBead Gene Expression Assay puts HTG's qNPA chemistry technology on the Luminex xMAP multiplexing platform to create a high-throughput assay with a simplified workflow that requires no extractions, cDNA synthesis, or amplifications, Luminex said today.

The qBead assay is used to acquire gene expression data from degraded samples or difficult samples, such as formalin-fixed paraffin-embedded and other fixed tissues.

"The combination of xMAP Technology from Luminex and the qBead Assay represents an advance for many scientists, including cancer researchers who perform retrospective studies on large numbers of archived samples," Luminex CEO and President Patrick Balthrop said in a statement.

Balthrop also said that the partnership will use the two firms' technologies "to create high-throughput, custom assays that will advance the work of researchers in the critical, growing mid-plex custom gene expression research arena."

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.